1)norethisterone tabletsȲŵͪƬ
Ó¢ÎĶ̾ä/Àý¾ä
1.Analysis of the Uncertainty of the Content and the Content Uniformity in HPLC Determination of Norethisterone TabletsHPLC·¨²â¶¨È²ÅµÍªÆ¬º¬Á¿¼°º¬Á¿¾ùÔȶȵIJ»È·¶¨¶È·ÖÎö
2.Determination of content of levonorgestrel and quinestrol tablets by HPLCHPLCÍâ±ê·¨²â¶¨×óȲŵÔÐͪȲ´ÆÃÑÆ¬º¬Á¿
3.desogestrel ethinylestradiolÍÑÑõȲŵͪÒÒȲ´Æ¶þ´¼
4.Study on Dissolution Test for Compound Levonorgestrel Tabelts;¸´·½×óȲŵÔÐͪƬÈܳö¶ÈÊÔÑé·½·¨µÄÑо¿
5.Study on Transdermal Compound Levonorgestrel and Estradiol Patch¸´·½×óȲŵÔÐͪ/´Æ¶þ´¼Í¸Æ¤ÎüÊÕÌùƬµÄÑÐÖÆ
6.Determination of Main Component in Compound Levonorgestrel Tablet by HPLC¸ßЧҺÏàÉ«Æ×·¨²â¶¨¸´·½×óȲŵÔÐͪƬµÄº¬Á¿
7.Pharmacokinetics and Bioequivalence Study of Levonorgestrel Dispersible Tablets in Healthy Volunteers×óȲŵÔÐͪ·ÖɢƬÔÚ½¡¿µÈËÌåÖеÄÒ©¶¯Ñ§ºÍÉúÎïµÈЧÐÔ
8.Determination of assay and content uniformity of compound levonorgestrel tablets and its pills¸´·½×óȲŵÔÐͪƬºÍµÎÍ躬Á¿¼°º¬Á¿¾ùÔȶȲⶨ
9.Two years multicentre clinical study of sino-implant type I for using contraceptive (levonorgestrel silastic rod)×óȲŵÔÐͪ¹è½º°ôµÄ¶àÖÐÐÄÁÙ´²Ñо¿
10.Pharmacokinetics and bioequivalence of levonorgestrel tablet in healthy female volunteers×óȲŵÔÐͪƬÔÚ½¡¿µÖйúÅ®ÐÔÖ¾Ô¸ÕßÌåÄÚÒ©¶¯Ñ§¼°ÉúÎïµÈЧÐÔÑо¿
11.Preliminary Studies on the Contents of Testosterone, Estradiol and Norethisterone in Wild and Cultured Swamp Eel»Æ÷ÌåÄÚØºÍª¡¢´Æ¶þ´¼ºÍȲŵͪº¬Á¿µÄ¼ì²â·ÖÎö
12.The Treatment of the Levonorgestrel-releasing Intra-uterine System on Gynecologic Diseases;×óȲŵÔÐͪ¹¬ÄÚ½ÚÓýϵͳÓÃÓÚ¸¾¿Æ¼²²¡µÄÖÎÁÆ
13.The Levonorgestrel-releasing Intrauterine System:An Updated Review of the Noncontraceptive Uses×óȲŵÔÐͪ¹¬ÄÚ»ºÊÍϵͳµÄ·Ç±ÜÔÐÁÙ´²Ó¦ÓÃ
14.Comparison of clinical effects of levonorgestrel-releasing intrauterine system and Tcu380A×óȲŵÔÐͪ¹¬ÄÚ»ºÊÍϵͳÓëTcu380AÁÙ´²Ð§¹û±È½Ï
15.Clinical Applications Research of Levonorgestrel-releasing Intrauterine System×óȲŵÔÐͪ¹¬ÄÚ»ºÊÍϵͳÁÙ´²Ó¦ÓÃÑо¿
16.A progestational hormone, C20H26O2, similar in effect to progesterone, used especially in oral contraceptives.ȲŵͪºÏ³ÉµÄ±ÜÔм¤ËØ£¬C20H26O2£¬ÀàËÆ»ÆÌåͪµÄҩЧ£¬ÓÈÆäÓÃ×÷¿Ú·þ±ÜÔÐÒ©
17.The comparison research of nore thindrone (NID) and mifepristone (Ru486) to treat menopausal transition uterine bleedingȲŵͪ¡¢Ã×·Ç˾ͪÖÎÁƾø¾¹ý¶ÉÆÚ¹¦ÄÜÐÔ×Ó¹¬³öѪµÄ¶Ô±ÈÐÔÑо¿
18.The Regulating Characteristics of Progesterone and 18-methyl Levonorgestrel on Osteoblastic Cells;ÔÐͪºÍ18-¼××óȲŵÔÐͪ¶Ô³É¹Çϸ°û×÷ÓûúÖÆµÄÑо¿
Ïà¹Ø¶Ì¾ä/Àý¾ä
Norethisterone compositae¸´·½È²ÅµÍªÆ¬
3)enovid['i:n?vid]ÒìȲŵͪ-Ȳ´Æ´¼¼×ÃÑÆ¬
4)Levonorgestrel and quinestrol tablets×óȲŵÔÐͪȲ´ÆÃÑÆ¬
5)norethisteroneȲŵͪ
1.The Analysis of Human Urine Metabolites of the Contraceptive Drug Norethisterone by GC-MS;ÈËÄòÖбÜÔÐҩȲŵͪ´úлÎïµÄGC-MS·ÖÎö
2.Analysis of the Uncertainty of the Content and the Content Uniformity in HPLC Determination of Norethisterone TabletsHPLC·¨²â¶¨È²ÅµÍªÆ¬º¬Á¿¼°º¬Á¿¾ùÔȶȵIJ»È·¶¨¶È·ÖÎö
3.In this study,the synthetic hormones such as 17¦Á-ethinylestriadiol,levonorgestrel and norethisterone in sediment were determined by gas chromatography-mass spectrometry(GC-MS).Ó¦ÓÃÆøÏàÉ«Æ×-ÖÊÆ×ÁªÓü¼Êõ,½¨Á¢Á˵×ÄàÖкϳɼ¤ËØÈ²´Æ´¼¡¢×óȲŵÔÐͪºÍȲŵͪµÄ·ÖÎö·½·¨,ÓÅ»¯ÁËǰ´¦ÀíÌõ¼þ¡£
6)norgestrel[Ó¢][n?:'d?estr?l][ÃÀ][n?r'd??str?l]Ȳŵͪ
1.Study on Drug Delivery System of Poly(methylª² vinylsiloxane) and Levonorgestrel by Small Angle Laser Scattering;×óÐý18-¼×»ùȲŵͪ-¹èÏ𽺻ºÊÍÌåϵС½Ç¼¤¹âÉ¢Éä·¨Ñо¿
ÑÓÉìÔĶÁ
ȲŵͪƬ¡¾Í¨ÓÃÃû³Æ¡¿È²ÅµÍªÆ¬ ¡¾ÆäËûÃû³Æ¡¿È²ÅµÍªÆ¬ ȲŵͪƬ Æ´ÒôÃû£ºQuenuotong Pian Ó¢ÎÄÃû£ºNorethisterone Tablets ÊéÒ³ºÅ£º2000Äê°æ¶þ²¿£421 ±¾Æ·º¬È²ÅµÍª(C20H26O2)ӦΪ±êʾÁ¿µÄ90.0£¥¡«110.0 £¥¡£ ¡¾ÖÆ·¨¡¿ È¡ÊÊÒ˸¨ÁÏÖÆ³ÉƬо£¬Íâ°üº¬È²ÅµÍªÌÇÒ¡£ ¡¾ÐÔ×´¡¿ ±¾Æ·ÎªÌÇÒÂÆ¬¡£ ¡¾¼ø±ð¡¿ (1) È¡±¾Æ·µÄϸ·ÛÊÊÁ¿£¨Ô¼Ï൱ÓÚȲŵͪ10mg£©£¬¼ÓÒÒ´¼1ml Èܽâºó£¬ ÀëÐÄ£¬È¡ÉÏÇåÒº£¬ÕÕȲŵͪÏîÏµļø±ð(1) ÏîÊÔÑ飬ÏÔÏàͬ·´Ó¦¡£ (2) È¡º¬Á¿²â¶¨ÏîϵÄÈÜÒº£¬ÕÕ·Ö¹â¹â¶È·¨£¨¸½Â¼¢ô A£©²â¶¨¡£ÔÚ240nmµÄ²¨³¤´¦ ÓÐ×î´óÎüÊÕ¡£ ¡¾¼ì²é¡¿ º¬Á¿¾ùÔÈ¶È È¡±¾Æ·1 Ƭ£¬ÖÃÈé²§ÖÐÑÐϸ£¬ÓÃÎÞË®ÒÒ´¼ÊÊÁ¿£¬·Ö´Î×ªÒÆ ÖÁ100ml Á¿Æ¿ÖУ¬²¢ÖÃˮԡÖб£ÎÂ15·ÖÖÓ£¬Ê±Ê±ÕñÒ¡£¬Ê¹È²ÅµÍªÈܽ⣬·ÅÀäÖÁÊÒΣ¬¼Ó ÎÞË®ÒÒ´¼Ï¡ÊÍÖÁ¿Ì¶È£¬Ò¡ÔÈ£¬Â˹ý£¬È¡ÐøÂËÒº£¬ÕÕ·Ö¹â¹â¶È·¨£¨¸½Â¼¢ô A£©ÔÚ240nm µÄ ²¨³¤´¦²â¶¨ÎüÊÕ¶È£¬°´C20H26O2µÄÎüÊÕϵÊý£¨£Å1% 1cm£©Îª571 ¼ÆËã³öÿƬº¬È²ÅµÍªµÄ Á¿¡£º¬Á¿¾ùÔȶȵÄÏÞ¶ÈΪ¡À20£¥£¬Ó¦·ûºÏ¹æ¶¨£¨¸½Â¼¢ú E£©¡£ ÆäËû Ó¦·ûºÏƬ¼ÁÏîÏÂÓйصĸ÷Ïî¹æ¶¨£¨¸½Â¼¢ñ A£©¡£ ¡¾º¬Á¿²â¶¨¡¿ È¡±¾Æ·20Ƭ£¬¾«Ãܳƶ¨£¬ÑÐϸ£¬¾«ÃܳÆÈ¡ÊÊÁ¿£¨Ô¼Ï൱ÓÚȲŵͪ10 mg£©ÖÃ100ml Á¿Æ¿ÖУ¬¼ÓÎÞË®ÒÒ´¼ÊÊÁ¿£¬ÕñҡʹȲŵͪÈܽ⣬ÓÃÎÞË®ÒÒ´¼Ï¡ÊÍÖÁ¿Ì¶È£¬ Ò¡ÔÈ£¬Â˹ý£¬¾«ÃÜÁ¿È¡ÐøÂËÒº5ml £¬ÖÃ50mlÁ¿Æ¿ÖУ¬¼ÓÎÞË®ÒÒ´¼Ï¡ÊÍÖÁ¿Ì¶È£¬Ò¡ÔÈ£¬ÕÕ ·Ö¹â¹â¶È·¨£¨¸½Â¼¢ô A£©ÔÚ240nm µÄ²¨³¤´¦²â¶¨ÎüÊÕ¶È£¬°´C20H26O2µÄÎüÊÕϵÊý£¨£Å1% 1cm£©Îª571 ¼ÆË㣬¼´µÃ¡£ ¡¾Àà±ð¡¿ ͬȲŵͪ¡£ ¡¾¹æ¸ñ¡¿ (1) 0.625mg (2) 2.5mg ¡¾Öü²Ø¡¿ Õڹ⣬ÃÜ·â±£´æ¡£
